Physician profile
Dmitry Chuprun
NPI 1568656544
$10,227.48
in general payments reported to CMS, 2019-2025
23 companies · $485 in 2025
The $485 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,424 · 2020: $299 · 2021: $289 · 2022: $377 · 2023: $2,329 · 2024: $5,025 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,616 · Food and Beverage: $2,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,615.64 |
| Food and Beverage | $2,222.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,206.71 | 2019-2025 | Watchman, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $3,224.32 | 2021-2025 | Evera Mri Xt Dr Surescan, Azure Xt Dr Mri Surescan, Micra |
| Biosense Webster, INC. | $891.56 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Abbott Laboratories | $414.57 | 2022-2025 | Amplatzer Amulet, Aveir, Perclose Prostyle |
| Pfizer INC. | $224.57 | 2020-2025 | |
| Medtronic Vascular, INC. | $198.34 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $170.15 | 2021-2024 | Optimizer, Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $152.04 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $143.56 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $126.60 | 2020-2024 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $78.70 | 2024-2025 | Farxiga, Lokelma, Wainua |
| Amgen INC. | $77.70 | 2022-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.17 | 2023-2024 | Jardiance |
| Cvrx, INC. | $53.28 | 2023-2024 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $36.97 | 2019-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $31.98 | 2025 | |
| Cordis US Corp. | $28.15 | 2024 | Mynx Venous Vcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.38 | 2025 | Lifevest |
| Inspire Medical Systems, INC. | $18.88 | 2025 | Inspire |
| Cardiva Medical, INC. | $18.39 | 2022 | |
| Scpharmaceuticals INC. | $17.23 | 2025 | |
| Novo Nordisk INC | $16.63 | 2023 | Ozempic, Rybelsus |
| Davol INC. | $15.60 | 2023 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitry Chuprun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.